Advanced Biomed Common Stock Net Income
| ADVB Stock | 0.29 0.05 14.71% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Advanced Biomed's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Net Loss | -2.5 M | -2.6 M | |
| Net Loss | -116.8 K | -122.6 K |
Advanced | Net Income | Build AI portfolio with Advanced Stock |
Advanced Biomed Common Company Net Income Analysis
Advanced Biomed's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Advanced Biomed Net Income | (101.52 K) |
Most of Advanced Biomed's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Advanced Biomed Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Advanced Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Advanced Biomed is extremely important. It helps to project a fair market value of Advanced Stock properly, considering its historical fundamentals such as Net Income. Since Advanced Biomed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Advanced Biomed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Advanced Biomed's interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Advanced Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Advanced Biomed Common reported net income of (101,524). This is 100.03% lower than that of the Health Care Equipment & Supplies sector and 100.06% lower than that of the Health Care industry. The net income for all United States stocks is 100.02% higher than that of the company.
Advanced Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Advanced Biomed's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Advanced Biomed could also be used in its relative valuation, which is a method of valuing Advanced Biomed by comparing valuation metrics of similar companies.Advanced Biomed is currently under evaluation in net income category among its peers.
Advanced Fundamentals
| Return On Equity | -1.65 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 3.69 M | ||||
| Shares Outstanding | 21.64 M | ||||
| Shares Owned By Insiders | 77.53 % | ||||
| Shares Owned By Institutions | 1.21 % | ||||
| Number Of Shares Shorted | 662.89 K | ||||
| Price To Book | 2.10 X | ||||
| EBITDA | (90.81 K) | ||||
| Net Income | (101.52 K) | ||||
| Total Debt | 1.26 M | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (181.46 K) | ||||
| Short Ratio | 0.43 X | ||||
| Earnings Per Share | (0.17) X | ||||
| Number Of Employees | 31 | ||||
| Market Capitalization | 6.31 M | ||||
| Total Asset | 6.51 B | ||||
| Retained Earnings | (19.23 B) | ||||
| Working Capital | 318.65 K | ||||
| Net Asset | 6.51 B |
About Advanced Biomed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Advanced Biomed Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Advanced Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Advanced Biomed Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out Advanced Biomed Piotroski F Score and Advanced Biomed Altman Z Score analysis. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Advanced Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Advanced Biomed Common is measured differently than its book value, which is the value of Advanced that is recorded on the company's balance sheet. Investors also form their own opinion of Advanced Biomed's value that differs from its market value or its book value, called intrinsic value, which is Advanced Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Advanced Biomed's market value can be influenced by many factors that don't directly affect Advanced Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Advanced Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Advanced Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Advanced Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.